Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100474466> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3100474466 endingPage "652" @default.
- W3100474466 startingPage "648" @default.
- W3100474466 abstract "Abstract Use of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, on the basis of spontaneous adverse event reports, has recently been suspected of causing splanchnic vein thrombosis. Here, we report the results of a population‐based new‐user active comparator cohort study addressing this hypothesis, comparing DPP‐4 inhibitor initiators (n = 75 042) with initiators of glucagon‐like‐peptide‐1 receptor agonists (GLP‐1RAs) or sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors (n = 38 718). We estimated the hazard ratio (HR) associating DPP‐4 inhibitor use with risk of splanchnic vein thrombosis using Cox regression. In a crude analysis, the incidence rate of splanchnic vein thrombosis was 0.22/1000 person‐years among DPP‐4 inhibitor initiators, compared to 0.17 among GLP‐1RA/SGLT2 inhibitor initiators, corresponding to an unadjusted absolute incidence rate difference of 0.05 (95% confidence interval [CI] –0.04 to 0.14) and an HR of 1.29 (95% CI 0.78 to 2.15). Adjusting for potential confounders using stabilized inverse probability of treatment weighing, we obtained an absolute incidence rate difference of 0.03/1000 person‐years (95% CI –0.07 to 0.14) and an HR of 1.18 (95% CI 0.62 to 2.26). No evidence of increased risk of splanchnic vein thrombosis was found in supplementary analyses, including an absence of any dose–response patterns. As such, we found no association between DPP‐4 inhibitor use and splanchnic vein thrombosis risk." @default.
- W3100474466 created "2020-11-23" @default.
- W3100474466 creator A5024486402 @default.
- W3100474466 creator A5034451758 @default.
- W3100474466 creator A5047991194 @default.
- W3100474466 creator A5068333335 @default.
- W3100474466 creator A5072859924 @default.
- W3100474466 creator A5086275374 @default.
- W3100474466 creator A5089401828 @default.
- W3100474466 date "2020-11-26" @default.
- W3100474466 modified "2023-10-18" @default.
- W3100474466 title "Use of dipeptidyl peptidase‐4 inhibitors and risk of splanchnic vein thrombosis: A <scp>Danish</scp> nationwide new‐user active comparator cohort study" @default.
- W3100474466 cites W1556662366 @default.
- W3100474466 cites W1978670003 @default.
- W3100474466 cites W1981535076 @default.
- W3100474466 cites W2009187570 @default.
- W3100474466 cites W2024198422 @default.
- W3100474466 cites W2080699399 @default.
- W3100474466 cites W2126049444 @default.
- W3100474466 cites W2219591537 @default.
- W3100474466 cites W3009151641 @default.
- W3100474466 cites W3019281704 @default.
- W3100474466 cites W4253996779 @default.
- W3100474466 doi "https://doi.org/10.1111/dom.14253" @default.
- W3100474466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33184953" @default.
- W3100474466 hasPublicationYear "2020" @default.
- W3100474466 type Work @default.
- W3100474466 sameAs 3100474466 @default.
- W3100474466 citedByCount "2" @default.
- W3100474466 countsByYear W31004744662021 @default.
- W3100474466 countsByYear W31004744662023 @default.
- W3100474466 crossrefType "journal-article" @default.
- W3100474466 hasAuthorship W3100474466A5024486402 @default.
- W3100474466 hasAuthorship W3100474466A5034451758 @default.
- W3100474466 hasAuthorship W3100474466A5047991194 @default.
- W3100474466 hasAuthorship W3100474466A5068333335 @default.
- W3100474466 hasAuthorship W3100474466A5072859924 @default.
- W3100474466 hasAuthorship W3100474466A5086275374 @default.
- W3100474466 hasAuthorship W3100474466A5089401828 @default.
- W3100474466 hasBestOaLocation W31004744662 @default.
- W3100474466 hasConcept C126322002 @default.
- W3100474466 hasConcept C167704817 @default.
- W3100474466 hasConcept C178853913 @default.
- W3100474466 hasConcept C207103383 @default.
- W3100474466 hasConcept C2775849017 @default.
- W3100474466 hasConcept C2780011451 @default.
- W3100474466 hasConcept C2780868729 @default.
- W3100474466 hasConcept C2908647359 @default.
- W3100474466 hasConcept C44249647 @default.
- W3100474466 hasConcept C71924100 @default.
- W3100474466 hasConcept C90924648 @default.
- W3100474466 hasConcept C99454951 @default.
- W3100474466 hasConceptScore W3100474466C126322002 @default.
- W3100474466 hasConceptScore W3100474466C167704817 @default.
- W3100474466 hasConceptScore W3100474466C178853913 @default.
- W3100474466 hasConceptScore W3100474466C207103383 @default.
- W3100474466 hasConceptScore W3100474466C2775849017 @default.
- W3100474466 hasConceptScore W3100474466C2780011451 @default.
- W3100474466 hasConceptScore W3100474466C2780868729 @default.
- W3100474466 hasConceptScore W3100474466C2908647359 @default.
- W3100474466 hasConceptScore W3100474466C44249647 @default.
- W3100474466 hasConceptScore W3100474466C71924100 @default.
- W3100474466 hasConceptScore W3100474466C90924648 @default.
- W3100474466 hasConceptScore W3100474466C99454951 @default.
- W3100474466 hasIssue "2" @default.
- W3100474466 hasLocation W31004744661 @default.
- W3100474466 hasLocation W31004744662 @default.
- W3100474466 hasOpenAccess W3100474466 @default.
- W3100474466 hasPrimaryLocation W31004744661 @default.
- W3100474466 hasRelatedWork W1516595110 @default.
- W3100474466 hasRelatedWork W1751560915 @default.
- W3100474466 hasRelatedWork W2117092782 @default.
- W3100474466 hasRelatedWork W2117097169 @default.
- W3100474466 hasRelatedWork W2154967465 @default.
- W3100474466 hasRelatedWork W2461984565 @default.
- W3100474466 hasRelatedWork W2900720613 @default.
- W3100474466 hasRelatedWork W2915034084 @default.
- W3100474466 hasRelatedWork W3198175280 @default.
- W3100474466 hasRelatedWork W4213424932 @default.
- W3100474466 hasVolume "23" @default.
- W3100474466 isParatext "false" @default.
- W3100474466 isRetracted "false" @default.
- W3100474466 magId "3100474466" @default.
- W3100474466 workType "article" @default.